Bristol Myers Squibb

ORENCIA

Manufacturer:

Bristol Myers Squibb

Orencia HCPCS:

J0129

HCPCS Code Descriptor:

Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Category:

J Code

Orencia NDCs:

00003-2187-13, 00003-2818-11, 00003-2188-11, 00003-2188-51, 00003-2814-11

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Orencia CPT Codes:

Potential CPT administration codes for Orencia can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Orencia:

ORENCIA is an Immunology:Anti-TNF drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J0129 is aligned to the drug ORENCIA.

Orencia, also known as Abatacept, is a modified antibody. Orencia is used to treat rheumatoid arthritis, a condition in which a patient's body attacks healthy tissue. Orencia works by helping to reduce your immune system response, thus relieving symptoms such as joint pain and swelling. Orencia can also be used to treat other forms of arthritis, such as juvenile idiopathic arthritis and psoriatic arthritis.

ACCESS PRICING AND MORE BY REGISTERING

J0129 Added Date:

January 1, 2007

J0129 Effective Date:

January 1, 2012

J0129 Termination Date:

HCPCS Active

Orencia billing and coding information can be found through Bristol Myers Squibb at the link below:
Orencia patient assistance information can be found through Bristol Myers Squibb’s Patient Access Foundation at the URL: http://www.bmspaf.org
ORENCIA prescribing information can be found at the link below:
Information regarding ORENCIA’s side effects can be found at MedlinePlus